Menu

​Chinese biotech shares surge as Big Pharma looks to license cancer treatments 

​Chinese biotech shares surge as Big Pharma looks to license cancer treatments 

Sector returns are over 60% this year, with investors impressed by rapid pace of innovation 

Leave a Reply

Your email address will not be published. Required fields are marked *

You might also like...

​Trump asked Zelenskyy if Ukraine could hit Moscow, say people briefed on call 

​Trump asked Zelenskyy if Ukraine could hit Moscow, say people…

US president encouraged Ukrainian leader to step up deep strikes on Russia 

Learn more
​FTSE 100 hits 9,000 points for first time 

​FTSE 100 hits 9,000 points for first time 

UK stocks benefit from investors diversifying away from US 

Learn more
​Nvidia gets nod from Washington to resume sales of H20 China chip 

​Nvidia gets nod from Washington to resume sales of H20…

Leading AI chipmaker had taken $4.5bn writedown after tightening US controls banned export of its…

Learn more

Have any questions?

Whatsapp Now

+60 17-3011741

Email Address

[email protected]

Facebook Instagram X-twitter Tiktok
Copyright © 2025 Fizzyx Digital | Powered by Fizzyx Digital